BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Zeus Scientific Inc. to Offer a Rapid Nasal Screening Test for Methicillin-resistant Staphylococcus Aureus (MRSA)


7/10/2008 11:32:59 AM

RARITAN, N.J., July 9 /PRNewswire/ -- Zeus Scientific, Inc. today announced its intention to offer a rapid nasal screening test for methicillin-resistant Staphylococcus aureus (MRSA). The test is based upon Zeus' own proprietary technology utilizing the enrichment and nucleic acid amplification of a target pathogen.

Available through the Zeus worldwide distribution network, the new MRSA test will enable healthcare professionals to identify carriers of this pathogen within two hours. Published studies have shown that time-to-results is critical in demonstrating a reduction in MRSA hospital infection rates.

In addition to significantly improving assay performance over other technologies in this product space, the nasal MRSA test will be offered as a low cost alternative to the two currently FDA approved MRSA PCR products without sacrificing time to results or performance.

Zeus is uniquely positioned in this area through relevant patent filings, further expanding its Intellectual Property portfolio and providing new product protection.

About Zeus Scientific, Inc.

Zeus Scientific, Inc. is a global leader in the field of clinical diagnostics products. Zeus has a developing pipeline of innovative, high quality, and cost-effective diagnostic solutions geared toward the enhancement of patient care. Zeus' products are marketed and distributed worldwide through a vast network of quality distribution partnerships.

For additional information about the nasal screening test for MRSA, please contact Zeus at 908-526-3744 or visit our web site at www.zeusscientific.com.

CONTACT: James S. Vingara of Zeus Scientific, Inc., +1-908-526-3744,
jvingara@zeusscientific.com

Web site: http://www.zeusscientific.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES